- Home
- SPH vs ATRC Comparison
SPH vs ATRC Comparison
Compare SPH & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SPH | ATRC |
|---|---|---|
| Founded | 1945 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | 1996 | 2005 |
Fundamental Metrics
Financial Performance| Metric | SPH | ATRC |
|---|---|---|
| Price | $18.45 | $40.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $52.22 |
| AVG Volume (30 Days) | 119.9K | ★ 566.9K |
| Earning Date | 02-05-2026 | 10-29-2025 |
| Dividend Yield | ★ 6.94% | N/A |
| EPS Growth | ★ 42.10 | N/A |
| EPS | ★ 1.62 | N/A |
| Revenue | ★ $1,432,518,000.00 | $518,304,999.00 |
| Revenue This Year | $2.48 | $16.90 |
| Revenue Next Year | $1.16 | $12.29 |
| P/E Ratio | $11.59 | ★ N/A |
| Revenue Growth | 7.94 | ★ 15.80 |
| 52 Week Low | $16.92 | $28.29 |
| 52 Week High | $22.24 | $43.11 |
Technical Indicators
Market Signals| Indicator | SPH | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 42.26 | 60.03 |
| Support Level | $18.40 | $38.92 |
| Resistance Level | $18.82 | $42.60 |
| Average True Range (ATR) | 0.36 | 1.51 |
| MACD | -0.08 | 0.08 |
| Stochastic Oscillator | 19.40 | 70.23 |
Price Performance
Historical ComparisonAbout SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.